Fig 1
Fig 2
Fig 3
Fig 4
Absolute counts of leukocytes in the blood and in the BAL fluid in the control groups with saline instead of silica (Sal), in the silica-injected and non-treated animals (Sil), and in the silica-injected and dexamethasone-treated animals (Dex) after 14 or 28 days of the treatment delivery_
| 14 days | 28 days | |||||
|---|---|---|---|---|---|---|
| Leukocytes in the blood (x 109/L) | ||||||
| Sal14 | Sil14 | Dex14 | Sal28 | Sil28 | Dex28 | |
| Ly | 2.95±1.07 | 4.33±0.84 a | 1.99±0.87 g | 3.21±0.83 | 4.18±1.23 | 1.42±0.53 j |
| Neu | 0.63±0.19 | 0.97±0.40 | 1.14±0.40 | 0.61±0.22 | 0.67±0.22 | 1.49±0.79 h |
| Mo | 0.04±0.02 | 0.03±0.01 | 0.04±0.02 | 0.05±0.03 | 0.05±0.02 | 0.03±0.01 |
| Eo | 0.03±0.03 | 0.04±0.04 | 0.05±0.05 | 0.03±0.04 | 0.06±0.04 | 0.04±0.02 |
| Leukocytes in the BAL fluid (x 103/mL) | ||||||
| Sal14 | Sil14 | Dex14 | Sal28 | Sil28 | Dex28 | |
| Ma | 97.7±41.5 | 95.4±37.7 | 146±38.8 f | 107±45.9 | 102±43.8 | 84.3±42.4 |
| Neu | 2.29±1.66 | 14.3±3.83 c | 35.1±49.9 | 3.51±1.35 | 26.8±24.1 d | 8.68±5.23 |
| Eo | 0.25±0.32 | 0.81±0.23 b | 1.47±1.57 | 0.23±0.23 | 2.39±2.17 d | 0.62±0.35 h |
| Ly | 0.99±0.64 | 2.35±1.70 | 4.06±2.10 | 0.71±0.27 | 4.92±2.89 e | 1.40±0.87 i |